Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Total Debt: 2024-2025

Historic Total Debt for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $9.7 million.

  • Kura Oncology's Total Debt rose 2.12% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.4 million, marking a year-over-year change of. This contributed to the annual value of $9.5 million for FY2024, which is N/A change from last year.
  • Per Kura Oncology's latest filing, its Total Debt stood at $9.7 million for Q3 2025, which was up 0.54% from $9.6 million recorded in Q2 2025.
  • Kura Oncology's 5-year Total Debt high stood at $9.7 million for Q3 2025, and its period low was $9.4 million during Q1 2024.